hVIVO (LON:HVO) Share Price Crosses Below 200 Day Moving Average – Time to Sell?

Shares of hVIVO plc (LON:HVOGet Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 28.25 ($0.37) and traded as low as GBX 26.70 ($0.35). hVIVO shares last traded at GBX 27.30 ($0.36), with a volume of 10,117,770 shares traded.

hVIVO Price Performance

The stock has a market capitalization of £185.74 million, a PE ratio of 910.00 and a beta of 0.97. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The stock’s 50-day moving average is GBX 28.75 and its 200 day moving average is GBX 28.24.

Insider Activity

In related news, insider Cathal Friel sold 21,159,176 shares of the stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of GBX 29 ($0.38), for a total transaction of £6,136,161.04 ($8,030,573.28). 14.03% of the stock is currently owned by corporate insiders.

hVIVO Company Profile

(Get Free Report)

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.

Read More

Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.